These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 8985399)
1. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. Srikiatkhachorn A; Braciale TJ J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399 [TBL] [Abstract][Full Text] [Related]
2. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. Srikiatkhachorn A; Braciale TJ J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194 [TBL] [Abstract][Full Text] [Related]
3. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease. Spender LC; Hussell T; Openshaw PJ J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139 [TBL] [Abstract][Full Text] [Related]
4. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. Bembridge GP; Lopez JA; Cook R; Melero JA; Taylor G J Virol; 1998 May; 72(5):4080-7. PubMed ID: 9557697 [TBL] [Abstract][Full Text] [Related]
5. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246 [TBL] [Abstract][Full Text] [Related]
6. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323 [TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198 [TBL] [Abstract][Full Text] [Related]
8. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. Johnson TR; Graham BS J Virol; 1999 Oct; 73(10):8485-95. PubMed ID: 10482601 [TBL] [Abstract][Full Text] [Related]
9. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins. Jackson M; Scott R J Med Virol; 1996 Jul; 49(3):161-9. PubMed ID: 8818960 [TBL] [Abstract][Full Text] [Related]
10. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. Varga SM; Wissinger EL; Braciale TJ J Immunol; 2000 Dec; 165(11):6487-95. PubMed ID: 11086089 [TBL] [Abstract][Full Text] [Related]
11. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model. Liu J; Ruckwardt TJ; Chen M; Johnson TR; Graham BS J Virol; 2009 May; 83(10):4934-41. PubMed ID: 19264776 [TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review. Becker Y Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040 [TBL] [Abstract][Full Text] [Related]
13. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. Johnson TR; Parker RA; Johnson JE; Graham BS J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374 [TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914 [TBL] [Abstract][Full Text] [Related]
16. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. Hancock GE; Speelman DJ; Heers K; Bortell E; Smith J; Cosco C J Virol; 1996 Nov; 70(11):7783-91. PubMed ID: 8892899 [TBL] [Abstract][Full Text] [Related]
17. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. Olson MR; Hartwig SM; Varga SM J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987 [TBL] [Abstract][Full Text] [Related]
19. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. Castilow EM; Olson MR; Meyerholz DK; Varga SM J Virol; 2008 Mar; 82(5):2196-207. PubMed ID: 18094193 [TBL] [Abstract][Full Text] [Related]
20. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. Johnson TR; Johnson JE; Roberts SR; Wertz GW; Parker RA; Graham BS J Virol; 1998 Apr; 72(4):2871-80. PubMed ID: 9525607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]